The COVID-19 pandemic led to the rapid scaling up of production activities in the pharmaceutical industry. An increase in the number of FDA approvals in biologics has further accelerated biopharmaceutical production, particularly in North America and Asia. With a boom in biopharmaceuticals anticipated in the next 5 to 7 years, the demand for single-use solutions, such as pumps, bioreactors, mixers, tubing, connectors, consumables, and other instrumentation is expected to increase significantly. The cost and time efficiencies achieved with single-use pumps and other single-use technologies offer an optimistic growth outlook, particularly for the pharmaceutical industry. The demand for contract manufacturing organizations (CMOs) is becoming more pronounced and is expected to further accelerate the usage of the single-use solution.
In this study, Frost & Sullivan has identified, analyzed, and evaluated the existing and upcoming trends impacting the global single-use pumps and technologies market. The study offers insights into the growth prospects for single-use pump manufacturers for the next 5 years. It also discusses the product, market, and technology growth opportunities impacting the industry’s future. The regions covered include North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.
GROWTH PIPELINE DIALOG™
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.